Concepedia

Siddhartha Goutam

SG

7

Publications

229

Citations

7

H-Index

2019

Active since

Affiliations

University of Calgary(Current)

University of Alberta

Siddhartha Goutam is an author at University of Calgary specializing in oncology, cancer therapeutics, and lung cancer.

ORCID

Top concepts

Publications per year

2019–2023

7

Publications

7

Association of Immune-Related Adverse Events, Hospitalization, and Therapy Resumption With Survival Among Patients With Metastatic Melanoma Receiving Single-Agent or Combination Immunotherapy

Alexander Watson, Siddhartha Goutam, Igor Stukalin et al. · JAMA Network Open · 2022 · 58 citations · Full text

Combined poly-ADP ribose polymerase and ataxia-telangiectasia mutated/Rad3-related inhibition targets ataxia-telangiectasia mutated-deficient lung cancer cells

Nicholas Jette, Suraj Radhamani, Greydon Arthur et al. · British Journal of Cancer · 2019 · 48 citations · Full text

Outcomes of patients with solid tumour malignancies treated with first-line immuno-oncology agents who do not meet eligibility criteria for clinical trials

Chun Loo Gan, Igor Stukalin, Daniel E. Meyers et al. · European Journal of Cancer · 2021 · 46 citations · Full text

Effectiveness and Safety of First-Line Pembrolizumab in Older Adults with PD-L1 Positive Non-Small Cell Lung Cancer: A Retrospective Cohort Study of the Alberta Immunotherapy Database

Heidi A.I. Grosjean, Samantha Dolter, Daniel E. Meyers et al. · Current Oncology · 2021 · 27 citations · Full text

Impact of Performance Status on Survival Outcomes and Health Care Utilization in Patients With Advanced NSCLC Treated With Immune Checkpoint Inhibitors

Daniel E. Meyers, Meghann Pasternak, Samantha Dolter et al. · JTO Clinical and Research Reports · 2023 · 26 citations · Full text

, , +9

Rows per page

1–5 of 7